The OneVentures Team

All partners have many years of C-level, board and investment experience. Coupled with this is a track record of identifying investment opportunities in global markets with strong international business backgrounds and networks. The OneVentures Investment team has 7 technology related higher degrees.

Dr Michelle Deaker

Dr Michelle Deaker
Managing Partner

Dr Paul Kelly

Dr Paul Kelly
Managing Partner

Anne-Marie Birkill

Anne-Marie Birkill
Managing Partner

Graeme Wald

Graeme Wald
Principal, Healthcare

Dr Amir Zalcenstein

Dr Amir Zalcenstein
Investment Manager, Healthcare

James McGrath

James McGrath
Investment Analyst

Helen Liu

Helen Liu
Chief Financial Officer

Jelly Jakob

Jelly Jakob
Accounts

Jen Ball

Jen Ball
Office Manager

Board of Directors

Walter Lewin

Walter Lewin
OneVentures Board of Directors

Simon Moore

Simon Moore
OneVentures Board of Directors

Roger Massy-Greene

Roger Massy-Greene
OneVentures Board of Directors

Dr Michelle Deaker

Managing Partner

Dr Michelle Deaker

Michelle is the Founder, Managing Director and CEO of OneVentures. She is also a member of the Investment Committee and manages the Supervisory Board for OneVentures Funds. Michelle is a successful entrepreneur and business executive with over 18 years experience in information technology enterprise businesses targeting finance, retail, media, security and education. She serves on the Boards of Seven West Media (Channel7, yahoo7, Pacific Magazines and West Australian News) and NICTA, Australia’s National ICT Centre of Excellence. She is a member of the AVCAL Venture Capital Working Group and was a member of and consulted on the NSW Government’s Taskforce for the Digital Economy.

Dr Paul Kelly

Managing Partner

Dr Paul Kelly

Paul is a founding partner and serves as a member of the Investment Committee and Risk Management Committee and is Managing Director of the Fund Manager. An Australian physician, serial entrepreneur and experienced biotechnology and life sciences executive, he currently has over 30 years experience in clinical medicine and medical science and 20 years experience in commercialising life science related technologies in Australia, Europe and North America.

Anne-Marie Birkill

Managing Partner

Anne-Marie Birkill

Anne-Marie is a Founding Partner, member of the Investment Committee, Executive Director of the Manager and Chair of the Risk Management Committee based in Brisbane, a strong source of early stage technology innovation opportunities. She has over 25 years experience in commercialization and product development, during which time she has worked with hundreds of early stage technology companies and entrepreneurs as director, senior executive, mentor and business coach.

Dr Graeme Wald

Principal, Healthcare

Graeme Wald

Prior to joining One Ventures Graeme was Investment Director at BioScience Managers - a specialist Life Science Fund Manager.

As non-executive director of Nexvet Biopharma he was chairman of the Audit and Risk committee and assisted in guiding the company to a NASDAQ listing.

Whilst at Wilson HTM, as head of Life Science Research, Graeme was rated top analyst in the pharmaceutical sector as measured by Starmine against recommendations and investor returns.

Graeme is originally from South Africa. Whilst at Merill Lynch he was rated top analyst in the Pharmaceutical and Healthcare sector. He was also a member of the top rated Global Paper and Pulp Research team.

Graeme has a broad range of sector experience. He has covered sectors including Life Sciences, pharmaceuticals, health care, transport, and paper and pulp. He also has experience in setting general industrial investment strategies.

Graeme has worked in Israel, America and South Africa as a research chemist in the industrial and energy sectors.

He holds a PhD in chemistry and an MBA from the University of the Witwatersrand.

Dr Amir Zalcenstein

Investment Manager, Healthcare

Dr Amir Zalcenstein

Amir Zalcenstein has recently relocated to Melbourne from Israel and expands OneVentures' life sciences sector capability. Prior to joining OneVentures and while in Israel, Amir was Head of Business Development for BiondVax, a publicly traded company developing a Universal Flu Vaccine. Prior, Amir served as CEO of Amorphical (developing the next generation of Calcium-based therapies) and SoluBest, a drug delivery company advancing a proprietary technology for oral delivery of insoluble drugs.

Amir holds a PhD in Molecular Biology from the Weizmann Institute of Science and an Executive MBA from Technion, Israel.

Amir brings a strong Israeli venture perspective to the team and extensive international operational experience.

James McGrath

Investment Analyst

James McGrath

James joined OneVentures in 2015 as an Investment Analyst.

James joined OneVentures from Allier Capital, a boutique investment bank focused on helping high growth TMT, consumer and health companies raise capital and achieve exits. Prior to this James worked in investment banking at Citi, Credit Suisse and Merrill Lynch and was a research intern at The Department of Foreign Affairs and Trade (China Economics Desk).

His role encompasses opportunity identification, due diligence, negotiation, portfolio company support and exit strategy.

James holds a Bachelor of Commerce and a Bachelor of Arts, with majors in Economics and Politics from the University Of Melbourne (Trinity College).

James is a keen squash player and runner.

Helen Liu

Chief Financial Officer

Helen Liu

Helen is responsible for OneVentures' accounting, fund administration and all compliance activities. Helen is also responsible for the financial and company secretarial affairs for 3 OneVentures investee companies. Helen has over 20 years of experience in accounting, finance, fund management and investment with 12 years spent in various executive roles with Allen & Buckeridge, an Australian venture capital firm.

Jelly Jakob

Accounts

Jelly Jakob

Jelly is responsible for assisting in OneVentures' daily accounting, fund administration and compliance activities. Jelly has over 11 years of fund accounting experience having started her financial services career with Allen & Buckeridge in Sydney.

Walter Lewin

OneVentures Board of Directors

Walter Lewin

Mr Lewin is Chair of the Board and Investment Committee for OneVentures Pty Ltd. He is a member of the Advisory Board of VGI Partners, a leading global investment firm based in Sydney and New York. Mr Lewin was a founding shareholding and Chair of the Advisory Board of OneVue (ASX: OVH) and was a founding shareholder and Executive Director of Reverse Corp (ASX: REF). Previously, he was a Managing Director of Ord Minnett and member of its Group Management Committee, a Principal of Elysium Capital Partners in London, a Managing Director (Equities) for Merrill Lynch in London after holding several positions in the Equities and Investment Banking divisions of SBC (now UBS) in London and SBC Dominguez Barry (now UBS) in Sydney.

Mr Lewin received a Bachelor of Commerce (First Class Honours) and a Bachelor of Laws (Honours) from University of Queensland. He was a visiting lecturer in business finance at the Queensland Institute of Technology. He received the Baillieu Research award (1989).

Simon Moore

OneVentures Board of Directors

Simon Moore

Simon Moore is Managing Director and a Global Partner of The Carlyle Group. Prior to joining The Carlyle Group in 2005, Simon was a Managing Director and Investment Committee Member of Investcorp International, Inc. based in New York. Prior to that, Simon worked in private equity investments and investment banking at J.P. Morgan & Co. in New York, Hong Kong and Melbourne.

Current Directorships
Partner and Managing Director: The Carlyle Group (Sydney, Australia).
Chairman: Coates Hire Ltd.
Alternate Director: Qube Holdings Limited.
Non-Executive Director: Megaport Limited; TPI Enterprises Limited.

Roger Massy-Greene

OneVentures Board of Directors

Roger Massy-Greene

Mr Massy-Greene is the Chair of Ausgrid, the electricity distribution company that serves eastern Sydney and the Hunter Valley. He is also the Chair of Endeavour Energy, which distributes electricity in western Sydney and the Illawarra region. From 2012 to 2016 he was the Chair of Essential Energy, which distributes electricity in rural and regional NSW, from 2012 to 2016.

He is also currently a director of OneVentures Pty Ltd, a technology venture capital firm, and is the principal shareholder and Chair of Eureka Capital Partners, a private investment concern. He previously co-founded the ASX 200 company Excel Coal Limited and its predecessor Resource Finance Corporation Ltd, and served as Chair of Excel Coal until its acquisition by Peabody Energy in 2006.

Mr Massy-Greene serves as Chair of the Salvation Army’s Sydney Advisory Committee and of Eureka Benevolent Foundation, a family foundation focused on overcoming socio-economic disadvantage. He is the President of Cranbrook School and a director of The Hunger Project in the USA and Australia.